A Leading Pharmaceutical Brand Increased Adherence 29% YoY with Swoop’s Patented Predictive Non-Adherence Audiences
With an increased incidence in substance use disorders (SUDs), a MAT therapy wanted to increase adherence within its patient population to drive positive patient outcomes. Leveraging Swoop’s patented predictive technology, the brand was able to accurately identify patients most likely to become non-adherent and activate them programmatically across premium inventory.
Advertising on CTV Increases HCP Appointments for Mental Health Drug by 20%
A pharmaceutical brand needed to connect with a limited patient population diagnosed with a sensitive conditionand their caregivers. Swoop utilized its privacy-safe real world health data to create a targetable niche segment for activation on CTV platforms.
Help patients start and stay on therapy programs prescribed by their doctors
SwoopRx by Nimble connects prescription fulfillment capabilities with commercial intelligence to turn real-world signals into action, improve medication adherence, and reduce treatment delays.
Celebrating the innovative and impactful use of conversational AI technology, CUSTOMER magazine awarded Swoop a 2024 Conversational AI Excellence Award.
Swoop's new conversational AI platform allows pharma brands to engage in 24/7, MLR-compliant near-human interaction with ideal customers in the moment of need.
Swoop has just launched its audience building with predictive AI segments to create ideal DTC and HCP segments for proactive engagement at critical moments in the health journey.
Swoop’s privacy-safe patient segments can now be used by healthcare marketers to plan activation across iHeartMedia’s industry-leading broadcast radio ecosystem.
Swoop re-imagines traditional 1:1 HCP advertising using ML/AI in conjunction with RWD to uncover critical brand ambassadors that are typically overlooked.